Champions Biotechnology Changes Name to Champions Oncology

Hackensack, NJ – April 4, 2011 – Champions Biotechnology, Inc. (OTC : CSBR) (“the Company”) announced today that it has changed its name to Champions Oncology, Inc.

The name change reflects the Company’s new strategic focus on developing advanced techonologies to personalize the development and use of oncology drugs. As a result of this new focus, the Company does not currently plan to in-license any additional compounds in the future.